glp-1 for autoimmune Lower Risk Of Death Clots Among Patients Taking GLP1 Drugs GLP-1-based meds are linked to
Description
doi: 10.1111/exd.13442 [DOI] [PubMed] [Google Scholar] 178
Herein, we report that pharmacologic stimulation of the cell GLP-1R activates cell PC1/3 and GLP-1 expression
Offer subcutaneous semaglutide up to 1 mg once weekly for CV, renal and glycaemic benefits (no specific guidance on tirzepatide or oral semaglutide because CVOT results were unavailable at time of review)
Genome Biol (2004) 5(3):214
Drugs used to treat obesity and for weight loss alone have not been covered by Medicare previously
This dual effect supports both weight loss and overall metabolic health
